Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Viela Bio Inc.

Latest From Viela Bio Inc.

Roche Mounts NMOSD Challenge To Alexion’s Soliris

Satralizumab will be boosted by convenience and MS portfolio in increasingly competitive field.

Neurology Clinical Trials

ECTRIMS Preview: Ocrevus Success Brings Rivals Crowding In

The congress will highlight competition in anti-CD20 and other novel multiple sclerosis drug classes

Neurology Clinical Trials

Keeping Track: CDER Ties Monthly Novel Approval Record With Nourianz Green Light

The latest drug development news and highlights from our US FDA Performance Tracker. 

Approvals Drug Review

Finance Watch: Summer Slowdown Nears Its End With Strategic Shifts And IPO Hopes

Merrimack's wind-down continues with an activist challenge, but investors approved the Vical/Brickell Biotech reverse merger. Also, the past month's IPO slump may reverse course and HiFiBiO's $67m Series C leads recent financings.

Financing Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
  • Therapeutic Areas
  • Immune Disorders
  • Inflammation
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Company Type
  • Start-Up
  • Parent & Subsidiaries
  • Viela Bio Inc.
  • Senior Management
  • Bing Yao, PhD, CEO
    Mitchell Chan, CFO
    Jorn Drappa, MD, PhD, Head, R&D & CMO
    Aaron Ren, PhD, Head, Bus. Dev. & Operations
  • Contact Info
  • Viela Bio Inc.
    One MedImmune Way, 1st Fl.
    Area 2
    Gaithersburg, MD 20878